# Isoprinosine in HIV Patients With Viral Load > 50 y < 200 Copies/mL

> **NCT03883334** · PHASE4 · UNKNOWN · sponsor: **Universidad San Francisco de Quito** · enrollment: 60 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Metisoprinol

## Key facts

- **NCT ID:** NCT03883334
- **Lead sponsor:** Universidad San Francisco de Quito
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-28
- **Primary completion:** 2020-03-30
- **Final completion:** 2020-06-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2019-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03883334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03883334, "Isoprinosine in HIV Patients With Viral Load > 50 y < 200 Copies/mL". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03883334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*